Data as of Aug 29
| +0.15 / +10.71%|
Implant Sciences Corp. develops and manufactures explosive trace detection sensors and systems that are capable of detecting minute amounts of a wide variety of military, commercial, and homemade explosives. The company has developed proprietary technologies used in its commercial explosives and drugs trace detection systems that ship to a growing number of locations internationally. Its products are Quantum Sniffer QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and the company's QS-B220 bench top explosives and narcotics trace detector has received a Developmental Testing & Evaluation Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002. The company was founded in August 1984 and is headquartered in Wilmington, MA.
|Glenn D. Bolduc||Chairman, President, CEO & Head-Investor Relations|
|William J. McGann||Chief Operating Officer & Director|
|Roger P. Deschenes||Chief Financial Officer & Vice President|
|Todd A. Silvestri||Vice President-Technology & Product Development|
|Brenda L. Baron||Vice President-Manufacturing & Technical Services|